Deciphera Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DECIPHERA PHARMS, and when can generic versions of DECIPHERA PHARMS drugs launch?
DECIPHERA PHARMS has one approved drug.
There are fifteen US patents protecting DECIPHERA PHARMS drugs.
There are sixty-eight patent family members on DECIPHERA PHARMS drugs in thirteen countries.
Summary for Deciphera Pharms
| International Patents: | 68 |
| US Patents: | 15 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Deciphera Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,266,635 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,395,818 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,426,390 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,612,591 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,576,904 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,185,535 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,529,336 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Deciphera Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 3163051 | ⤷ Try a Trial |
| China | 114303195 | ⤷ Try a Trial |
| South Korea | 20110074633 | ⤷ Try a Trial |
| Eurasian Patent Organization | 200970280 | ⤷ Try a Trial |
| Israel | 293864 | ⤷ Try a Trial |
| Mexico | 2009002813 | ⤷ Try a Trial |
| Japan | 2023509628 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
